Literature DB >> 31652990

Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments.

Jesus Manuel Ramirez-Acuña1, Sergio A Cardenas-Cadena2, Pedro A Marquez-Salas3,4, Idalia Garza-Veloz5,6, Aurelio Perez-Favila7,8, Miguel A Cid-Baez9, Virginia Flores-Morales10, Margarita L Martinez-Fierro11,12.   

Abstract

Diabetic foot ulcers (DFUs) are very important diabetes-related lesions that can lead to serious physical consequences like amputations of limbs and equally severe social, psychological, and economic outcomes. It is reported that up to 25% of patients with diabetes develop a DFU in their lifetime, and more than half of them become infected. Therefore, it is essential to manage infection and ulcer recovery to prevent negatives outcomes. The available information plays a significant role in keeping both physicians and patients aware of the emerging therapies against DFUs. The purpose of this review is to compile the currently available approaches in the managing and treatment of DFUs, including molecular and regenerative medicine, antimicrobial and energy-based therapies, and the use of plant extracts, antimicrobial peptides, growth factors, ozone, devices, and nano-medicine, to offer an overview of the assessment of this condition.

Entities:  

Keywords:  antimicrobial therapy; diabetic foot ulcer; regenerative medicine

Year:  2019        PMID: 31652990     DOI: 10.3390/antibiotics8040193

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  13 in total

1.  Screening of Natural Molecules as Adjuvants to Topical Antibiotics to Treat Staphylococcus aureus from Diabetic Foot Ulcer Infections.

Authors:  Diana Oliveira; Anabela Borges; Maria J Saavedra; Fernanda Borges; Manuel Simões
Journal:  Antibiotics (Basel)       Date:  2022-05-04

Review 2.  Nanoceutical Adjuvants as Wound Healing Material: Precepts and Prospects.

Authors:  Kaushita Banerjee; Radha Madhyastha; Yuichi Nakajima; Masugi Maruyama; Harishkumar Madhyastha
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

3.  Efficacy of hyperbaric oxygen therapy for diabetic foot ulcer, a systematic review and meta-analysis of controlled clinical trials.

Authors:  Rakesh Sharma; Suresh K Sharma; Shiv Kumar Mudgal; Prasuna Jelly; Kalpana Thakur
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

4.  Eugenol-Containing Essential Oils Loaded onto Chitosan/Polyvinyl Alcohol Blended Films and Their Ability to Eradicate Staphylococcus aureus or Pseudomonas aeruginosa from Infected Microenvironments.

Authors:  Joana C Antunes; Tânia D Tavares; Marta A Teixeira; Marta O Teixeira; Natália C Homem; M Teresa P Amorim; Helena P Felgueiras
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

5.  Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs.

Authors:  Haroon Mohammad; Nader S Abutaleb; Alexandra M Dieterly; L Tiffany Lyle; Mohamed N Seleem
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

Review 6.  Photodynamic disinfection and its role in controlling infectious diseases.

Authors:  Rafael T Aroso; Fábio A Schaberle; Luís G Arnaut; Mariette M Pereira
Journal:  Photochem Photobiol Sci       Date:  2021-10-27       Impact factor: 3.982

7.  Novel topical allogeneic bone-marrow-derived mesenchymal stem cell treatment of hard-to-heal diabetic foot ulcers: a proof of concept study.

Authors:  Jonas Askø Andersen; Anne Rasmussen; Marie Frimodt-Møller; Susanne Engberg; Esther Steeneveld; Klaus Kirketerp-Møller; Timothy O'Brien; Peter Rossing
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

Review 8.  Strategies in Translating the Therapeutic Potentials of Host Defense Peptides.

Authors:  Darren Shu Jeng Ting; Roger W Beuerman; Harminder S Dua; Rajamani Lakshminarayanan; Imran Mohammed
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

9.  Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice.

Authors:  Haroon Mohammad; Nader S Abutaleb; Alexandra M Dieterly; L Tiffany Lyle; Mohamed N Seleem
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240

Review 10.  Bioactive Antimicrobial Peptides as Therapeutic Agents for Infected Diabetic Foot Ulcers.

Authors:  Jessica Da Silva; Ermelindo C Leal; Eugénia Carvalho
Journal:  Biomolecules       Date:  2021-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.